Ian Schofield
Executive Editor
Latest From Ian Schofield
Australia To Give Consumers More Formal Role In HTA Processes
The health department says consumers and patients should be able to initiate health technology assessments because many potentially helpful and lifesaving medicines might never be assessed for funding due to “a lack of commercial incentive for pharmaceutical companies.”
EC Defends Data Protection Cut As EU ‘Pharma Package’ Nears Crucial Milestone
Proposals to overhaul the general pharmaceutical legislation will ensure that the EU “continues to have one of the most generous systems of incentives in the world,” the European Commission says.
European Parliament Clears EU-Wide Compulsory Licensing Proposal
The draft regulation, which includes a ban on exports of drugs manufactured under an EU compulsory license, will be discussed with the EU member states after the June parliamentary elections.
European Parliament Clears EU-Wide Compulsory Licensing Proposal
The draft regulation, which includes a ban on exports of drugs manufactured under an EU compulsory license, will be discussed with the EU member states after the June parliamentary elections.
EU’s New Variations Rules Will Cut Regulatory Burden, But Some Are Less Happy Than Others
Among the key features of the new framework are “super-grouping” of variations, a risk-based approach to classifying changes to biological products, and a more streamlined approach to updating pandemic vaccines.
First ‘Critical Medicines’ To Undergo EU Vulnerability Assessment
Data are now being collected from the pharmaceutical industry and the EU member states to inform an assessment of the risk of supply chain issues for some critical medicines.